Associate Dean for Clinical Innovation and EBP
Rutgers University - Camden Nursing
Joseph D. Tariman, Ph.D., MBA, ANP-BC, FAAN
Associate Professor and Associate Dean for Clinical Innovation
School of Nursing
Rutgers University - Camden
530 Federal Street
Suite 423
Camden, NJ 08102
Email: jt1164@rutgers.edu
Dr. Joseph Tariman is an internationally renowned researcher, educator, and clinician whose significant contributions to the literature impact the clinical care of older adults with myeloma and have earned him a prestigious Fellowship into the American Academy of Nursing (FAAN), the highest honor bestowed to a nurse in the United States. He began his research career in 2002 as a member of the myeloma program research team at Northwestern University. He assumed key investigator roles in many clinical drug trials in myeloma, which gave him the opportunity and credibility to serve as a key opinion leader, editor of the only myeloma book for nurses (1st, 2nd, and 3rd editions), and co-authorship in eight myeloma-related book chapters. His research is focused on shared decision-making processes and their patient-reported outcomes. He has developed several instruments including the Acceptability Scale, Shared-Decision Making Competency for Nurses, and Values and Preferences Elicitation Questionnaire, which have been translated into French, Spanish, Chinese, Finnish, Swedish, Norwegian, and Estonian languages. He has received funding from the National Institute of Health, the Oncology Nursing Society, the University Research Council, and Non-Profit Organizations and Foundations. He is a founding member of the International Myeloma Foundation’s Nurse Leadership Board that guides other myeloma nurse clinicians in manuscript preparation, submission, and publication of numerous articles on clinical topics such as novel myeloma therapies, management of novel treatment-related side effects in myeloma, cancer survivorship, health maintenance, stem cell transplantation, and outcomes measurement.